首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Comparison of the Clinical Characteristics and Outcomes Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant E. faecium Bacteremia
【2h】

Comparison of the Clinical Characteristics and Outcomes Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant E. faecium Bacteremia

机译:耐万古霉素肠球菌和耐万古霉素肠球菌细菌血症的临床特征和结果的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In published studies, cohorts of patients with bacteremia due to vancomycin-resistant Enterococcus (VRE) have predominantly been infected with Enterococcus faecium. Little is known about the epidemiology and outcomes associated with bacteremia due to VR Enterococcus faecalis. A retrospective study of isolates obtained from January 2008 to October 2010 was conducted at Detroit Medical Center (DMC). Unique patients with blood cultures positive for VRE were reviewed. Outcomes were analyzed using logistic regression. During the study period, 105 cases of bacteremia due to VR E. faecalis and 197 cases of bacteremia due to VR E. faecium were identified. The mean age in the study cohort was 61.5 ± 15 years; 162 subjects (53.6%) were male. After controlling for a propensity score, bacteremia due to VR E. faecalis was associated with >2-fold-lower in-hospital mortality than bacteremia due to VR E. faecium. Interestingly, bacteremia due to VR E. faecalis was associated with longer hospital stay after VRE isolation, although total length of stay was similar for groups with VR E. faecalis and VR E. faecium. Bacteremia due to VR E. faecalis was associated with a >2-fold-lower risk for mortality than bacteremia due to VR E. faecium, possibly due to the availability of β-lactam therapeutics for treatment of VR E. faecalis.
机译:在已发表的研究中,由于耐万古霉素肠球菌(VRE)导致的菌血症患者队列主要感染了粪肠球菌。关于因粪便肠球菌引起的菌血症的流行病学和结局知之甚少。在底特律医学中心(DMC)进行了从2008年1月至2010年10月获得的分离株的回顾性研究。回顾了血液培养对VRE阳性的独特患者。结果采用逻辑回归分析。在研究期间,确定了105例由VR粪便引起的菌血症和197例由VR粪便引起的菌血症。该研究队列的平均年龄为61.5±15岁。 162名受试者(53.6%)为男性。在控制了倾向得分后,VR粪便致死菌血症的院内死亡率比VR粪便致菌血症的院内死亡率低> 2倍。有趣的是,VR粪肠球菌引起的菌血症与VRE隔离后住院时间更长有关,尽管VR粪肠球菌和VR粪肠球菌的总住院时间相似。与粪便VR所致菌血症相比,由粪便E. E.粪便引起的细菌血症的死亡风险要高2倍以上,这可能是由于β-内酰胺疗法可用于治疗粪便E.粪便。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号